Lugano Financial Advisors SA (LFA)’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-371
Closed -$106K 183
2023
Q2
$106K Hold
371
0.07% 98
2023
Q1
$103K Sell
371
-509
-58% -$141K 0.08% 66
2022
Q4
$244K Sell
880
-880
-50% -$249K 0.18% 50
2022
Q3
$470K Buy
1,760
+880
+100% +$187K 0.37% 46
2022
Q2
$179K Hold
880
0.13% 65
2022
Q1
$186K Hold
880
0.12% 66
2021
Q4
$211K Hold
880
0.12% 63
2021
Q3
$249K Hold
880
0.16% 59
2021
Q2
$305K Hold
880
0.19% 49
2021
Q1
$246K Buy
+880
New +$237K 0.17% 57

Other funds holding BIIB

Lugano Financial Advisors SA (LFA)'s BIIB Position: Q3 2023 in Review

Lugano Financial Advisors SA (LFA) sold out of Biogen (BIIB) in Q3 2023, closing a stake of 371 shares — an estimated $106K sold.

Lugano Financial Advisors SA (LFA) first reported a position in BIIB in Q1 2021 and held it in 10 quarters. The position peaked at $470K in Q3 2022. 965 funds tracked by Wall St. Rank hold BIIB as of Q3 2023.

  • Lugano Financial Advisors SA (LFA) reported no remaining Biogen position as of Q3 2023 after selling out during the quarter.
  • Lugano Financial Advisors SA (LFA) sold 371 Biogen shares in Q3 2023, an estimated $106K.
  • Lugano Financial Advisors SA (LFA) first reported a position in Biogen in Q1 2021 and held it in 10 quarters.
  • Lugano Financial Advisors SA (LFA)'s Biogen position peaked at $470K in Q3 2022.
  • 965 funds tracked by Wall St. Rank held Biogen as of Q3 2023.

Based on Lugano Financial Advisors SA (LFA)'s 13F filing for Q3 2023, filed 23 Oct 2023.